Recombinant Human OVCA2 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human OVCA2 protein is a Human Full Length protein, in the 1 to 227 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
Esterase OVCA2, Ovarian cancer-associated gene 2 protein, OVCA2
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human OVCA2 protein (AB130016)
15% SDS-PAGE analysis of ab130016 (3 μg).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OVCA2 impacts cellular processes by modulating protein dynamics and stability. Through its isomerase activity it contributes to proper protein folding and maintenance. It participates in cellular stress response by ensuring proteins maintain their correct conformation under changing conditions. There is limited evidence that OVCA2 functions alone and it may interact with other molecular chaperones or be part of a protein complex although this is not definitively established yet.
Pathways
OVCA2 is likely involved in protein quality control mechanisms essential for cellular homeostasis. It intersects with the protein folding and ubiquitin-proteasome pathways which are critical for managing improperly folded proteins. Related proteins such as FKBP4 and cyclophilins might operate along with OVCA2 to regulate protein folding and degradation although specific interaction pathways still require further elucidation.
Specifications
Form
Liquid
Additional notes
ab130016 is purified using conventional chromatography techniques.
General info
Sequence similarities
Belongs to the LovG family.
Post-translational modifications
Proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL-60.
Target data
Complementary Products
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com